We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
From Apr 2019 to Apr 2024
By Adria Calatayud
Vectura Group PLC said Wednesday that it plans to go ahead with its plan to pay a special dividend, as it considers that a U.S. patent-litigation process with GlaxoSmithKline PLC is now fully resolved.
Vectura, a U.K. pharmaceuticals business specializing in inhaled medicines, said Glaxo hasn't petitioned the Supreme Court in relation to a U.S. patent litigation concerning Glaxo's Ellipta products, and that this was the final route of appeal.
To date, Vectura has received 127.6 million pounds ($177.9 million) from Glaxo in respect of the U.S. patent litigation, it said. Vectura said it can execute its growth plans without using these funds, which allow it to pay a special dividend of 19 pence a share, totaling GBP113 million, and to launch a share consolidation.
The share consolidation will replace every six existing shares with five new shares, Vectura said.
The special dividend and share consolidation are subject to shareholder approval. A general meeting is due to be held on May 27, Vectura said.
Shares in Vectura at 0712 GMT were up 3.9% at 116 pence.
Write to Adria Calatayud at adria.calatayud@dowjones.com
(END) Dow Jones Newswires
April 21, 2021 03:37 ET (07:37 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
